Cloud-based Learning Management System for regulated industries with FDA 21 CFR Part 11 and EU Annex 11 compliance, offering validated training management, electronic signatures, and audit trails.
Dokeos GxP LMS is a cloud-based Learning Management System (xLms platform) designed specifically for regulated industries requiring FDA 21 CFR Part 11 and EU Annex 11 compliance. The platform serves pharmaceutical, biotechnology, medical device, healthcare, and manufacturing organizations that need validated training management systems.
The solution provides comprehensive GxP-compliant training capabilities including protocol training, investigator qualification, study documentation management, and multi-site training coordination. Dokeos states a track record of supporting 15+ FDA inspections with no major findings, and cites 40 years of combined pharmaceutical industry experience within its team.
Dokeos states it serves over 2 million users across 400+ clients globally, with notable pharmaceutical customers including Alcon, Medtronic, IQVIA, Oxurion, Eli Lilly, Merck, and Ipsen. Dokeos mentions ISO 13485 certification, without a certifying body or certificate number stated. The platform delivers validated system capabilities with Computer System Validation (CSV) documentation, making it suitable for pharmaceutical companies requiring regulatory-compliant training management.
The cloud-based SaaS deployment model provides accessibility while maintaining the security and compliance standards required for regulated environments, including audit trails, electronic signatures, and comprehensive validation documentation. Whether the audit trail is tamper-proof is unstated.
Pharmaceutical Edition
Dokeos GxP LMS is the pharmaceutical and regulated industries edition, built specifically to meet FDA 21 CFR Part 11, EU Annex 11, and GxP compliance requirements. The platform includes validated system capabilities, CSV documentation, and regulatory-specific features for pharmaceutical training management.
Core Capabilities
FDA & GxP Compliance
International Standards
Data Integrity & Validation
Dokeos GxP LMS is delivered as a cloud-based SaaS platform, providing web browser access without requiring on-premise infrastructure. The xLms platform architecture is designed for regulated industries with security and compliance built into the cloud deployment.
The system provides validated cloud hosting with FDA 21 CFR Part 11 and EU Annex 11-compliant infrastructure, including secure data storage, encrypted communications, and continuous system monitoring. Access is role-based with granular permission controls, and the platform supports multi-site deployments for global pharmaceutical organizations.
Integration capabilities support connectivity with HR systems, quality management systems, and other enterprise applications. API documentation and integration methods are undisclosed. The platform is designed to work within regulated IT environments with standard web browsers, eliminating the need for specialised client software installations.
Dokeos GxP LMS is offered as a cloud-based SaaS subscription, typically priced per user or per site. No public pricing is disclosed.
As a validated system for regulated industries, pricing includes the platform subscription, validation documentation packages, implementation support, and ongoing compliance maintenance. The acquisition by Lyvia Group in 2024 may influence future pricing and commercial models.
Implementation of Dokeos GxP LMS includes system configuration, user setup, content migration, and validation activities required for regulated environments. The vendor provides CSV documentation as part of the validated system offering, which includes Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) protocols.
The implementation process involves configuration of organizational structure, user roles, training workflows, and compliance reporting requirements. Content migration support assists with transferring existing training materials into the GxP-compliant platform format. Validation assistance helps pharmaceutical companies meet regulatory requirements for computerized system validation.
Training services are provided to administrators and end users, with specialised focus on GxP compliance requirements and proper use of audit trail and electronic signature capabilities. Dokeos states its team brings 40 years of combined pharmaceutical experience to support regulatory-compliant implementations. Implementation timelines are undisclosed and would vary based on organisational size and complexity.
Anonymous feedback from pharmaceutical professionals using this solution
1.8 out of 5
Based on 2 verified reviews
What Users Like
Customer feedback describes the platform as suited to healthcare and pharmaceutical companies requiring FDA 21 CFR Part 11-compliant training management, citing the platform's regulatory compliance capabilities and validated-system approach. Dokeos states a track record of supporting 15+ FDA inspections with no major findings. Feedback also cites the cloud-based deployment model for its accessibility alongside required security and compliance standards, and the vendor team's pharmaceutical expertise, which Dokeos states totals 40 years of combined experience, for understanding regulatory requirements and industry-specific training needs.
What Users Dislike
User interface has been described as dated. This could impact user adoption and satisfaction, particularly for organisations expecting consumer-grade user experiences in enterprise software. The legacy interface design may indicate underlying technology that has not been recently modernised, though this does not necessarily impact compliance capabilities. Organisations prioritising user experience and modern design aesthetics may find the interface less appealing.
Help the community
Share your experience with Dokeos GxP LMS anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section